How to Buy Cervomed Stock
Cervomed Inc
CervoMed Inc. , a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.
Cervomed stock last closed at $1.95, down 9.72% from the previous day, and has decreased 78.42% in one year. It has underperformed other stocks in the Biotechnology industry by 0.63 percentage points. Cervomed stock is currently +2.52% from its 52-week low of $1.90, and -92.61% from its 52-week high of $26.38.
As of Dec 11, 2024, there are 8.25M shares of CRVO outstanding. The market value of CRVO is $16.09M. In the last 24 hours, 2.93M CRVO shares were traded.
How to Buy Cervomed Stock
Not sure how to invest in Cervomed stock? Here's how.
- Choose where to buy Cervomed stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you choose where to buy Cervomed stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your payment method and add your details.
- Evaluate Cervomed stock: The Cervomed ticker symbol is CRVO. Is Cervomed stock a good investment? Should you buy shares of CRVO? How do CRVO's underlying business fundamentals look? Do top analysts think Cervomed is a good buy? Why has CRVO's stock price moved recently? (Hint: Our stock research website can help you understand if CRVO is a good stock to buy).
- Execute your CRVO trade: Decide if you will purchase CRVO shares at the current market price or use a limit order to purchase CRVO shares at a specific price.
- Watch your investment in CRVO: Create a watchlist to get live updates on your position in Cervomed shares.
Step 1: Choose where to buy Cervomed stock
You need an online brokerage account to access the NASDAQ market and buy CRVO stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal information so you can buy CRVO stock today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new trading account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've created your account on one of the best stock trading apps, your next step is to transfer the money for your investment:
Watch the tutorial below if you need help transferring funds into your investment account.
Step 4: Evaluate Cervomed stock
Once you have decided on the best place to buy Cervomed stock, it's crucial to evaluate their stock before you buy, so you truly wrap your head around the risk as well as the opportunity.
Cervomed shares quick numbers
Cervomed Fundamentals
WallStreetZen was built to help average investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on CRVO's stock page.
How is CRVO stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge CRVO's fair value.
Using relative valuations measures:
- CRVO could be undervalued based on its P/B ratio of 0.35x, relative to Biotechnology industry P/B ratio of 5.62x
You can access additional valuation analysis on CRVO's stock here.
How do CRVO Financials look?
Passed Financial Due Diligence Checks:
- Total CRVO debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the CRVO balance sheet.
- CRVO has $46.66M in cash and short term investments. This is sufficient to cover its annual cash burn of $11.02M.
- CRVO has a low debt to equity ratio of 0.07.
- There are more short-term assets than short-term liabilities on the CRVO balance sheet.
- CRVO has cash burn of 11018363. It has enough cash and short-term investments to cover this for at least one year.
Failed Financial Due Diligence Checks:
- CRVO profit margin has gone down from -28.7% to -118.7% in the past year.
Do analysts think it's a good time to buy CRVO stock
Out of 7 sell side analysts who track CRVO, the consensus analyst rating on CRVO is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent CRVO Analyst Recommendations
Jeffrey Hung, a top 16% analyst from Morgan Stanley initiates coverage on CRVO with a strong buy rating and announces their CRVO price target of $35.00, on Jul 26, 2024.
Tyler Bussian, a bottom 20% analyst from Brookline Capital initiates coverage on CRVO with a strong buy rating and announces their CRVO price target of $63.00, on Jul 8, 2024.
You can dive deeper into what analysts are saying on the Cervomed stock forecast page.
Metrics for Advanced CRVO Traders
CRVO Growth Numbers
Last year, CRVO revenue was $10.07M. Over the past 1 years, CRVO's revenue has gone up by 116.29% per year. This was faster than the Biotechnology industry average of 64.81%.
Dive into CRVO's earnings and revenue performance here.
Who is buying/selling CRVO?
In the last year, executives and large shareholders at CRVO have bought more shares than they have sold.
William Robert Elder, CFO GC of CRVO, was the latest CRVO insider to buy. They bought $18,160.00 worth of CRVO stock on Aug 27, 2024.
Get more info about who owns CRVO shares here.
Does CRVO provide a stable income stream?
No, Cervomed doesn't provide an income stream by paying out dividends.
CRVO Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your CRVO trade
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount, use a limit order.
Press the Open Trade button and your broker will place your order.
If you need more help investing in stocks on eToro, click the how to video below:
Step 6: Watch your investment in CRVO
Now that you own some CRVO shares, you'll want to stay up-to-date on your new investment.
Add CRVO to a watchlist to get the latest updates about your CRVO stock.
CRVO Feed
How to Buy Stock in Cervomed
To reiterate, here are the 6 steps to buy stock in Cervomed:
- Choose where to buy Cervomed stock
- Create a brokerage account
- Deposit funds into your investment account
- Evaluate Cervomed stock
- Execute your CRVO trade
- Watch your investment in CRVO
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to monitor your investment in Cervomed, create your watchlist below.
Other "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.